Literature DB >> 9028111

[Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography].

U Okushiba1, M Takeda.   

Abstract

We performed fluorescein and indocyanine green (ICG) angiographies in 56 patients with central serous chorioretinopathy, and studied the choroidal lesions. In the early phase, choroidal filling with ICG was delayed in 77% in the area including focal leakage. Hypofluorescent findings around the site of focal leakage persisted through the phase in 23%, and we think this finding was caused by filling defect of the choriocapillaris. In the late phase, choroidal tissue staining by ICG was present in 82% in the area including focal leakage. Multiple areas of choroidal staining were also present in unaffected areas in 43% and in 62% of fellow eyes. Choroidal tissue staining by ICG was revealed in 48% in the area of choroidal filling delay, and this finding persisted after focal leakage had disappeared following photocoagulation. We think this finding was caused by choroidal vascular hyperpermeability. These findings suggest that choroidal circulatory disturbance and choroidal vascular hyperpermeability play a causative role in damage to the retinal pigment epithelium in central serous chorioretinopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028111

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  10 in total

1.  Three-dimensional imaging by spectral domain optical coherence tomography in central serous chorioretinopathy with fibrin.

Authors:  Sandeep Saxena; Neha Sinha; Shashi Sharma
Journal:  J Ocul Biol Dis Infor       Date:  2012-05-22

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  Axial length in unilateral idiopathic central serous chorioretinopathy.

Authors:  Hoseok Moon; Dae Yeong Lee; Dong Heun Nam
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

4.  Evaluation of nailfold videocapillaroscopy in central serous chorioretinopathy.

Authors:  Muhammet Kazim Erol; Ayse Balkarli; Devrim Toslak; Berna Dogan; Dogan Durmaz; Elçin Süren; Salih Altun; Mehmet Bulut; Veli Cobankara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-19       Impact factor: 3.117

5.  Relationship between mean platelet volume and central serous chorioretinopathy.

Authors:  Ayhan Dursun; Mustafa Ilker Toker; Ayşe Vural Ozec; Erman Bozali; Kadir Kirboga; Feyza Gulac Dursun; Haydar Erdogan; Aysen Topalkara; Mustafa Kemal Arici
Journal:  Int Ophthalmol       Date:  2016-04-25       Impact factor: 2.031

6.  Low-dose aspirin as treatment for central serous chorioretinopathy.

Authors:  Antonio Caccavale; Filippo Romanazzi; Manuela Imparato; Angelo Negri; Anna Morano; Fabio Ferentini
Journal:  Clin Ophthalmol       Date:  2010-08-09

7.  Treatment of central serous chorioretinopathy with topical NSAIDs.

Authors:  Sepehr Bahadorani; Kyle Maclean; Kendall Wannamaker; Edward Rickie Chu; Nathan Gresores; Jeong-Hyeon Sohn; Roberto Diaz-Rohena; Michael A Singer
Journal:  Clin Ophthalmol       Date:  2019-08-15

Review 8.  The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes.

Authors:  Konstantinos Giannopoulos; Maria Gazouli; Klio Chatzistefanou; Anthi Bakouli; Marilita M Moschos
Journal:  J Genomics       Date:  2021-01-01

Review 9.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24

10.  Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy.

Authors:  Alahmady Hamad Alsmman; Engy Mohamed Mostafa; Amr Mounir
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.